CSIMarket
 

Dr Reddy s Laboratories Limited  (RDY)
Other Ticker:  
 

Dr Reddy S Laboratories Limited's Working Capital Per Sales

RDY's Working Capital and Revenue growth



RDY Working Capital Per Revenue (Mar 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Mar 31 2022)
IV. Quarter
Y / Y Working Capital Change 66.18 % 66.18 % 66.18 % 66.18 % 16.25 %
Y / Y Revenue Change 5.87 % - - - 8.94 %
Working Capital Per Revenue 0.49 0.47 0.42 0.37 0.31
Total Ranking # 2425 # # # # 2345
Seq. Working Capital Change 0 % 0 % 0 % 66.18 % 0 %
Seq. Revenue Change - - - - -





Comment on RDY's Working Capital Per Revenue in the fourth quarter 2023
Dr Reddy S Laboratories Limited's Working Capital Per Revenue sequentially grew to 0.49 during the Q4 2023, a new company high.

Within Healthcare sector 77 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Working Capital Per Revenue total ranking has deteriorated in the fourth quarter 2023, compared to previous quarter from to 2425.
Working Capital Per Revenue Ranking
Within: No.
Industry # 35
Sector # 78
S&P 500 # 2425


Working Capital Per Revenue Statistics
High Average Low
0.49
0.37
0.31
(Mar 31 2023)   (Mar 31 2022)



Financial Statements
Dr Reddy S Laboratories Limited's Working Capital $ 1,474 Millions Visit RDY's Balance sheet
Dr Reddy S Laboratories Limited's Revenues $ 2,992 Millions Visit RDY's Income Statement
Where are RDY's Sales coming from? Visit RDY's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2023, within Healthcare Sector Working Capital Per Revenue
Intelgenx Technologies Corp   1.35 
Mirum Pharmaceuticals Inc   1.34 
Orthopediatrics Corp  1.34 
Glaukos Corp  1.31 
Ardelyx Inc   1.29 
Axonics Inc   1.25 
Cutera Inc   1.22 
Milestone Scientific Inc   1.20 
Scientific Industries Inc   1.18 
Intercept Pharmaceuticals inc   1.18 
Conformis inc   1.16 
Sensus Healthcare Inc   1.16 
Adma Biologics Inc   1.14 
Spero Therapeutics Inc   1.14 
Silk Road Medical Inc   1.14 
23andme Holding Co  1.12 
Iradimed Corporation  1.12 
Invitae Corporation  1.11 
Nevro Corp   1.11 
Nutriband Inc   1.10 
Talkspace Inc   1.09 
10x Genomics Inc   1.09 
Fonar Corporation  1.08 
Stereotaxis Inc   1.08 
Dynavax Technologies Corporation  1.07 
Neuronetics inc   1.07 
Vertex Pharmaceuticals Inc  1.06 
Avinger Inc   1.06 
Axsome Therapeutics Inc   1.05 
Regeneron Pharmaceuticals Inc   1.04 
Date modified: 2023-06-14T06:40:44+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com